Although the above studies indicated that FAK plays a critical role in the transition from neoplasia to full adenocarcinoma during ErbB2 tumour progression, whether FAK is required in established ErbB2 mammary tumour cells remained unclear. The gene discussed is ERBB2; the disease is neoplasm.